Impact of a Fermented Infant Formula in Weaning Babies
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bondues, France, 59910
- Cabinet Médical
-
Dunkerque, France, 59240
- Cabinet Médical
-
Lambersart, France, 59130
- Cabinet Médical
-
Lille, France, 59000
- Cabinet Médical
-
Lille, France, 59000
- Hopital Saint Vincent de Paul
-
Roncq, France, 59223
- Cabinet Médical
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Eutrophic infants, (± 2SD), healthy, male or female, of 2 months of age (± 1 week)
- Born at 37 weeks of amenorrhea or more
- Exclusively breastfed since birth
- Written informed consent given by both parents (or tutors) for study participation
- Parents (or tutors) agreeing on the follow-up by one of the study investigators
Exclusion Criteria:
- Infant with congenital or acquired immunodeficiency, whatever the aetiology
- Infant with a significant metabolic, organic or bowel disease which could interfere with the results of the present study,
- Infant with congenital and/or chromosomal malformation,
- Infant having received antibiotic therapy within the 3 weeks before the inclusion visit
- infant receiving a treatment susceptible to interfere with the measure of study parameters
- Antibiotic therapy per/pre/post partum > 48 h
- Infant needing the prescription of a specific milk (HA, without cow milk)
- Infant in a situation which could interfere with an optimal participation to the study, or which could represent a risk for the infant, according to the investigator.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: 1
Breastfed babies
|
Exclusively breastfed babies
Other Names:
|
|
Active Comparator: 2
Weaning with the standard milk
|
Weaning babies fed with the standard formula
Other Names:
|
|
Experimental: 3
Weaning with the fermented milk
|
Weaning babies fed with the fermented formula
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To determine the impact of a fermented infant formula on the intestinal microbiota in weaning babies
Time Frame: 2, 3 and 5 months of age
|
2, 3 and 5 months of age
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Describe the intestinal flora according to the nutrition group
Time Frame: 3 and 5 months of age
|
3 and 5 months of age
|
|
Compare the effect on enterobacteria and clostridium of a fermented formula vs. a standard formula toward the pursuit of breastfeeding
Time Frame: 3 months of age
|
3 months of age
|
|
Describe the growth, according to the nutrition group
Time Frame: 3 and 5 months of age
|
3 and 5 months of age
|
|
Describe the milk tolerance at the weaning according to the nutrition group
Time Frame: 3 and 5 months of age
|
3 and 5 months of age
|
|
Describe the infection signs according to the nutrition group
Time Frame: 3 and 5 months of age
|
3 and 5 months of age
|
|
Describe weight and height, current alimentation and potential infectious diseases since the visit at 5 months of age, according to the nutrition group
Time Frame: 9 months of age
|
9 months of age
|
|
Compare the effect on enterobacteria, clostridium and bifidobacteria of a fermented formula vs. a standard formula toward the pursuit of breastfeeding
Time Frame: 5 months of age
|
5 months of age
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Nicolas Kalach, MD, Hopital Saint Vincent de Paul
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- BL009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.